16
Participants
Start Date
January 3, 2018
Primary Completion Date
March 2, 2018
Study Completion Date
March 2, 2018
Sotagliflozin (SAR439954)
"Pharmaceutical form: Tablet~Route of administration: Oral"
Hydrochlorothiazide
"Pharmaceutical form: Tablet~Route of administration: Oral"
Investigational Site Number 8400001, Dallas
Lead Sponsor
Sanofi
INDUSTRY